Effect of real-time continuous glucose monitoring system in overweight or obese adults with prediabetes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004304

Enrollment

Registered

2019-10-11

Start date

2019-12-06

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : All participants receive a 12-week lifestyle intervention (diet and exercise). The control group was monitored self-monitoring blood glucose (SMBG) at least 2 times a day for initial

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. = BMI 23 kg/m2 2. impaired fasting glucose (fasting glucose 100 to 125?mg/dL) or impaired glucose tolerance (2-h plasma glucose during oral glucose tolerance test (OGTT) 140 - 199 mg/dl) or HbA1c 5.7% to 6.4%

Exclusion criteria

Exclusion criteria: 1. type 1 diabetes or type 2 diabetes or undergoing treatment for diabetes 2. clinical history including malignancy 3. fast history of cardiovascular disease (e.g. myocardial infarction, stroke), surgery, and trauma which may affect blood glucose within last 6 months 4. taking medication (e.g. glucocorticoid, antipsychotics, anticholinergic drug etc.) which affect blood glucose 5. acute infection within last 1 month 6. pregnancy

Design outcomes

Primary

Measure	Time frame
HbA1C change;weight(Kg) change	—

Secondary

Measure	Time frame
lipid profile (total cholesterol, triglyceride, LDL-cholesterol and HDL-cholesterol) change	—

Countries

Korea, Republic of

Contacts

Public ContactJEONGMI KIM

Pusan National University Hospital

Outcome results